Market Cap : 276.45 B | Enterprise Value : 287.6 B | PE Ratio : 9.64 | PB Ratio : 3.34 |
---|
NYSE:PFE has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NYSE:PFE has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Pfizer has the Financial Strength Rank of 7.
GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors:
1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.Pfizer's Interest Coverage for the quarter that ended in Mar. 2022 was 30.89. Pfizer's debt to revenue ratio for the quarter that ended in Mar. 2022 was 0.34. As of today, Pfizer's Altman Z-Score is 3.61.
For the Drug Manufacturers - General subindustry, Pfizer's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Pfizer's Financial Strength distribution charts can be found below:
* The bar in red indicates where Pfizer's Financial Strength falls into.
GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
Pfizer's Interest Expense for the months ended in Mar. 2022 was $-322 Mil. Its Operating Income for the months ended in Mar. 2022 was $9,948 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2022 was $34,416 Mil.
Pfizer's Interest Coverage for the quarter that ended in Mar. 2022 is
Interest Coverage | = | -1 | * | Operating Income (Q: Mar. 2022 ) | / | Interest Expense (Q: Mar. 2022 ) |
= | -1 | * | 9948 | / | -322 | |
= | 30.89 |
The higher the ratio, the stronger the company's financial strength is.
2. Debt to revenue ratio. The lower, the better.
Pfizer's Debt to Revenue Ratio for the quarter that ended in Mar. 2022 is
Debt to Revenue Ratio | = | Total Debt (Q: Mar. 2022 ) | / | Revenue | ||
= | (Short-Term Debt & Capital Lease Obligation | + | Long-Term Debt & Capital Lease Obligation) | / | Revenue | |
= | (636 | + | 34416) | / | 102644 | |
= | 0.34 |
3. Altman Z-Score.
Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
The zones of discrimination were as such:
When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.
Pfizer has a Z-score of 3.61, indicating it is in Safe Zones. This implies the Z-Score is strong.
Good Sign:
Altman Z-score of 3.61 is strong.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The maximum rank is 10. Companies with rank 7 or higher will be unlikely to fall into distressed situations. Companies with rank of 3 or less are likely in financial distress.
Pfizer has the Financial Strength Rank of 7.
Thank you for viewing the detailed overview of Pfizer's Financial Strength provided by GuruFocus.com. Please click on the following links to see related term pages.
Denton David M | officer: Chief Financial Officer & EVP | 1000 LOWE'S BOULEVARD MOORESVILLE NC 28117 |
Pao William | officer: Executive Vice President | C/O CORPORATE SECRETARY 235 EAST 42ND STREET NEW YORK NY 10017 |
Mcdermott Michael | officer: Executive Vice President | C/O PFIZER INC. CORPORATE SECRETARY 235 EAST 42ND STREET 235 EAST 42ND STREET NY 10017 |
Malik Aamir | officer: Executive Vice President | C/O PFIZER INC. CORPORATE SECRETARY 235 EAST 42ND STREET NEW YORK NY 10017 |
Carapezzi William R Jr | officer: Executive Vice President | 600 MOUNTAIN AVENUE MURRAY HILL NJ 07921 |
Sahni Payal | officer: Executive Vice President | ATTN: PFIZER CORP. SECRETARY 235 EAST 42ND ST. NEW YORK NY 10017 |
Desmond-hellmann Susan | director | 513 PARNASSUS AVENUE S126 SAN FRANCISCO CA 94143 |
Hockfield Susan | director | GENERAL ELECTRIC COMPANY 41 FARNSWORTH STREET BOSTON MA 02210 |
Damico Jennifer B. | officer: SVP & Controller | C/O PFIZER INC. CORPORATE SECRETARY 235 EAST 42ND STREET NEW YORK NY 10017 |
Quincey James | director | THE COCA-COLA COMPANY ONE COCA-COLA PLAZA ATLANTA GA 30313 |
Gottlieb Scott | director | MOLECULAR INSIGHT PHARMACEUTICALS 160 SECOND STREET CAMBRIDGE MA 02142 |
Fonseca Lidia | officer: Executive Vice President | 358 SOUTH MAIN STREET BURLINGTON NC 27215 |
Goettler Michael | officer: Group President | 1000 MYLAN BOULEVARD CANONSBURG PA 15317 |
Rogers Dawn | officer: Executive Vice President | 235 EAST 42ND STREET NEW YORK NY 10017 |
Littman Dan R. | director | ATTN: CORPORATE SECRETARY PFIZER INC. 235 E. 42ND ST NEW YORK NY 10017 |
Other Sources
By Fool 2022-03-24
By tipranks.com 2022-03-25
By tipranks.com 2022-03-25
By Zacks 2022-03-30
By Zacks 2022-03-30
By tipranks.com 2022-04-01
By Zacks 2022-03-25
By Zacks 2022-03-24
By Zacks 2022-03-22
By Zacks 2022-04-04
By tipranks.com 2022-03-28
By Zacks 2022-03-25